Overview：
AI machine in medical imaging. Our first product is AI assistant to radiologist to identify the breast cancers cells in the mammogram images.

Advantages of our technology：
- In the Digital Mammography Dream Challenge organized by US White house(Obama Period), FathomX's AI accuracy came out top 5 in the world and Top in Asia.
- FathomX AI product has been approved by Singapore regulatory Health Science Authority (HSA).
- With the clinical data, FathomX can show the improvement in reduction of false positive incidence and Interval cancers in a breast screening process.
- With clinical data, we can show that FathomX's AI is not localized in Singapore only. We have made a comparison study in 8 different region(Singapore, Malaysia, Thailand, Australia, Taiwan, Japan, Hong kong and China) in Asia Pacific.
- With clinical data, we can prove that FathomX AI can read more accurate in Asia ladies who have dense breast than our European AI company that have FDA and CE certification.
- Seamless integration into the clinical workflow.

Our business model：
Focus on Business to Business(B2B). Go To Approach is 2 Tier. (Go Local and Sell local). 4 target group of customers: (1) National Breast screen program (2) Public or Private Hospital. (3) Insurance companies (4) Digital Healthcare platform solution vendors. Revenue Model : First and 2nd years licensing model and subsequently based on scan per charge.

Our aim for business：
[Target department / division/ companies]
Preferably with the management team, breast surgeons, breast radiologist department and IT team.

[Principle Objective of exhibiting at GIF]
To find partners for technical tie-ups
To find joint venture partners
To find PoC partners
To find users

URL：
https://www.fathomx.co/